Language

English

Publication Date

9-1-2025

Journal

Laser Medicine & Surgery

DOI

10.1002/lsm.70048

PMID

40662278

PMCID

PMC12332241

PubMedCentral® Posted Date

7-15-2025

PubMedCentral® Full Text Version

Post-print

Abstract

Objectives: Cutaneous collagenous vasculopathy (CCV) is a rare, idiopathic microangiopathy marked by widespread telangiectasias and histologic vessel wall thickening. Due to its rarity and clinical overlap with other vascular conditions, CCV poses diagnostic and therapeutic challenges. This report highlights the successful use of pulsed dye laser (PDL) therapy in treating a case of extensive CCV.

Methods: A 40-year-old woman with a decade-long history of progressive telangiectasias involving the extremities, trunk, and forearms underwent treatment with a 595-nm PDL. Six treatment sessions were conducted over 14 months.

Results: The patient experienced significant improvement in erythema, telangiectasias, and associated discomfort, with sustained clinical response and substantial cosmetic benefit observed across all treated areas.

Conclusion: PDL is a safe and effective treatment for CCV, offering both symptomatic relief and cosmetic improvement. This case adds to limited existing literature supporting its use and highlights the importance of individualized laser parameters for optimal outcomes.

Keywords

Humans, Female, Lasers, Dye, Adult, Telangiectasis, Skin Diseases, Vascular, Low-Level Light Therapy, cutaneous collagenous vasculopathy, PDL, pulsed dye laser, telangiectasias, vascular lesion

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.